Overview

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

The primary objective is to cure multiple myeloma with less toxic allogeneic bone marrow transplantation while inducing renal allograft tolerance through mixed chimerism in patients with end stage renal failure and multiple myeloma

Phase:

Phase 1

Details

Lead Sponsor:

Massachusetts General Hospital

Treatments:

Antilymphocyte Serum
Cyclophosphamide
Cyclosporine
Cyclosporins